FimmCyte reposted this
FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund FimmCyte, a pioneering women’s health biotech, announces an investment of 1 million CHF as a convertible loan from the UZH Life Sciences Fund (LSF). FimmCyte’s most advanced program is a non-hormonal disease modifying treatment for endometriosis. 👉 Read more: https://lnkd.in/ec3DSBHn Mohaned Shilaih, Valentina Vongrad, Neil Goldsmith, Stephan Emmerth, Martyna Wroblewska, Virginia Ballotta #AccelerateInBasel #Therapeutics #Biotech #Innovation
Markus Kalousek
6mo
Congratulations, Mohaned & Valentina, happy to see that your pioneering work is being recognised
Eternal Life
5mo
Thrilled to see your enthusiasm for making the most out of life! 🌟 Remember, as Confucius once said, We have two lives, and the second begins when we realize we only have one. Training the mind to find the extraordinary in the ordinary is indeed the pathway to a rich life. Keep inspiring! ✨🚀
Dorothee Brumann
6mo
Thats so important! Congrats!
Hi Mohamed and Valentina, congrats!
Congratulations FimmCyte!
while this is good news, it's disappointing to see that one of the few companies developing novel and non-hormonal treatments for endometriosis cannot attract serious funding from biotech VCs. There is a lot of talk in the media and politics about the need to find treatments and better diagnostics for endometriosis, yet VCs are still reluctant to enter the field. Several governments are already investing significant amounts in basic research in endometriosis, and it would be great to see visionary VCs following this momentum - the time is ripe and the ROI for the ones that invest first in this new wave of endometriosis innovators will be immense!